Interleukin-17: A Promoter in Colorectal Cancer Progression
Joint Authors
Wu, Pin
Huang, Qi
Liu, Yang
Ye, Jun
Huang, Jian
Wu, Dang
Source
Journal of Immunology Research
Issue
Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2013-12-07
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
It is widely accepted that chronic inflammation plays an active role in cancer.
Inflammatory immunocytes and related cytokines in the tumor microenvironment are supposed to be a “double-edged sword” in colorectal cancer (CRC) initiation and progression.
Interleukin-17 (IL-17), a pleiotropic proinflammatory cytokine, can promote cancer-elicited inflammation and prevent cancer cells from immune surveillance.
Despite controversy, IL-17 is generally considered to be a promoter in CRC progression.
In this review, we devote to summarize the current progress regarding the role of IL-17 in tumor initiation and progression, as well as the prognostic value in CRC.
American Psychological Association (APA)
Wu, Dang& Wu, Pin& Huang, Qi& Liu, Yang& Ye, Jun& Huang, Jian. 2013. Interleukin-17: A Promoter in Colorectal Cancer Progression. Journal of Immunology Research،Vol. 2013, no. 2013, pp.1-7.
https://search.emarefa.net/detail/BIM-1006731
Modern Language Association (MLA)
Wu, Dang…[et al.]. Interleukin-17: A Promoter in Colorectal Cancer Progression. Journal of Immunology Research No. 2013 (2013), pp.1-7.
https://search.emarefa.net/detail/BIM-1006731
American Medical Association (AMA)
Wu, Dang& Wu, Pin& Huang, Qi& Liu, Yang& Ye, Jun& Huang, Jian. Interleukin-17: A Promoter in Colorectal Cancer Progression. Journal of Immunology Research. 2013. Vol. 2013, no. 2013, pp.1-7.
https://search.emarefa.net/detail/BIM-1006731
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1006731
